193 related articles for article (PubMed ID: 14529683)
1. Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus.
Leitao MM; Sonoda Y; Brennan MF; Barakat RR; Chi DS
Gynecol Oncol; 2003 Oct; 91(1):209-12. PubMed ID: 14529683
[TBL] [Abstract][Full Text] [Related]
2. Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence.
Goff BA; Rice LW; Fleischhacker D; Muntz HG; Falkenberry SS; Nikrui N; Fuller AF
Gynecol Oncol; 1993 Jul; 50(1):105-9. PubMed ID: 8349151
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.
Powless CA; Aletti GD; Bakkum-Gamez JN; Cliby WA
Gynecol Oncol; 2011 Sep; 122(3):536-40. PubMed ID: 21636114
[TBL] [Abstract][Full Text] [Related]
4. [Nodal and ovarian matastases in leiomyosaromas of uterus: report of a case].
Dai L; Song QJ
Zhonghua Bing Li Xue Za Zhi; 2010 Oct; 39(10):714-5. PubMed ID: 21176546
[No Abstract] [Full Text] [Related]
5. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy.
Giuntoli RL; Metzinger DS; DiMarco CS; Cha SS; Sloan JA; Keeney GL; Gostout BS
Gynecol Oncol; 2003 Jun; 89(3):460-9. PubMed ID: 12798712
[TBL] [Abstract][Full Text] [Related]
6. Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas.
Cass I; Li AJ; Runowicz CD; Fields AL; Goldberg GL; Leuchter RS; Lagasse LD; Karlan BY
Gynecol Oncol; 2001 Jan; 80(1):56-61. PubMed ID: 11136570
[TBL] [Abstract][Full Text] [Related]
7. Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses.
Bogani G; Tagliabue E; Ditto A; Signorelli M; Martinelli F; Casarin J; Chiappa V; Dondi G; Leone Roberti Maggiore U; Scaffa C; Borghi C; Montanelli L; Lorusso D; Raspagliesi F
Gynecol Oncol; 2017 Oct; 147(1):61-65. PubMed ID: 28779965
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma.
Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J
Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408
[TBL] [Abstract][Full Text] [Related]
9. Leiomyosarcoma of the uterine corpus with ovarian metastases in a 28-year-old woman: case report.
Vasiljevic M; Stanojevic D; Djukic M; Hajric A
Eur J Gynaecol Oncol; 2008; 29(1):98-100. PubMed ID: 18386477
[TBL] [Abstract][Full Text] [Related]
10. Uterine leiomyosarcoma metastatic to the sphenoid sinus: a case report and review of the literature.
Sandruck J; Escobar P; Lurain J; Fishman D
Gynecol Oncol; 2004 Feb; 92(2):701-4. PubMed ID: 14766270
[TBL] [Abstract][Full Text] [Related]
11. [Risk of lymph node metastases in patients with ovarian cancer].
Bidziński M; Radziszewski J; Panek G; Dańska-Bidzińska A
Ginekol Pol; 2003 Sep; 74(9):671-6. PubMed ID: 14674106
[TBL] [Abstract][Full Text] [Related]
12. The Risk of Para-Aortic Lymph Node Metastases in Apparent Early Stage Ovarian Cancer.
Bacalbasa N; Balescu I; Vilcu M; Dima S; Diaconu C; Iliescu L; Filipescu A; Dimitriu M; Brezean I
Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32138225
[No Abstract] [Full Text] [Related]
13. Incidence of para-aortic and pelvic lymph node metastases in epithelial carcinoma of the ovary.
Chen SS; Lee L
Gynecol Oncol; 1983 Aug; 16(1):95-100. PubMed ID: 6884834
[TBL] [Abstract][Full Text] [Related]
14. [Metastatic mechanisms of uterine malignancies and therapeutic consequences].
Lax SF; Tamussino KF; Lang PF
Pathologe; 2016 Nov; 37(6):549-556. PubMed ID: 27757531
[TBL] [Abstract][Full Text] [Related]
15. Does Lymphadenectomy Improve Survival in Uterine Leiomyosarcoma?
Tasci T; Karalok A; Taskin S; Ureyen I; Kımyon G; Tulek F; Ozfuttu A; Turan T; Tulunay G; Kose MF; Ortac F
Int J Gynecol Cancer; 2015 Jul; 25(6):1031-6. PubMed ID: 25853382
[TBL] [Abstract][Full Text] [Related]
16. Distribution pattern and risk factors of pelvic and para-aortic lymph node metastasis in epithelial ovarian carcinoma.
Tsumura N; Sakuragi N; Hareyama H; Satoh C; Oikawa M; Yamada H; Yamamoto R; Okuyama K; Fujino T; Sagawa T; Fujimoto S
Int J Cancer; 1998 Oct; 79(5):526-30. PubMed ID: 9761124
[TBL] [Abstract][Full Text] [Related]
17. Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study.
Seagle BL; Sobecki-Rausch J; Strohl AE; Shilpi A; Grace A; Shahabi S
Gynecol Oncol; 2017 Apr; 145(1):61-70. PubMed ID: 28317559
[TBL] [Abstract][Full Text] [Related]
18. Early-stage cervical adenocarcinoma treated by surgical intent: the role of para-aortic lymph node dissection.
Lea JS; Sheets EE; Duska LR; Miller DS; Schorge JO
Gynecol Oncol; 2002 Feb; 84(2):285-8. PubMed ID: 11812088
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer.
Horowitz NS; Dehdashti F; Herzog TJ; Rader JS; Powell MA; Gibb RK; Grigsby PW; Siegel BA; Mutch DG
Gynecol Oncol; 2004 Dec; 95(3):546-51. PubMed ID: 15581961
[TBL] [Abstract][Full Text] [Related]
20. Site-specific factors for cancer of the corpus uteri from SEER registries: collaborative stage data collection system, version 1 and version 2.
Jamison PM; Altekruse SF; Chang JT; Zahn J; Lee R; Noone AM; Barroilhet L
Cancer; 2014 Dec; 120 Suppl 23():3836-45. PubMed ID: 25412395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
